Literature DB >> 3472222

Human immunodeficiency virus can productively infect cultured human glial cells.

C Cheng-Mayer, J T Rutka, M L Rosenblum, T McHugh, D P Stites, J A Levy.   

Abstract

Six isolates of the human immunodeficiency virus (HIV) showed differences in their ability to productively infect glioma-derived cell lines and early-passage human brain cell cultures. Susceptibility to HIV infection correlated well with the expression of the astrocyte marker glial fibrillary acidic protein. The CD4 molecule was expressed on some, but not all, of the brain-derived cells; however, no correlation was observed between CD4 protein expression and susceptibility to virus infection. The results show that HIV can productively infect human brain cells, particularly those of glial origin, and suggest that these cell types in the brain can harbor the virus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3472222      PMCID: PMC304904          DOI: 10.1073/pnas.84.10.3526

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  The role of glial fibrillary acidic protein in the diagnosis of central nervous system tumors.

Authors:  J H Deck; L F Eng; J Bigbee; S M Woodcock
Journal:  Acta Neuropathol       Date:  1978-06-30       Impact factor: 17.088

2.  GFA and S 100 protein levels as an index for malignancy in human gliomas and neurinomas.

Authors:  C M Jacque; M Kujas; A Poreau; M Raoul; P Collier; J Racadot; N Baumann
Journal:  J Natl Cancer Inst       Date:  1979-03       Impact factor: 13.506

3.  Lack of requirement of murine leukemia virus for early steps in infection of mouse embryo cells by murine sarcoma virus.

Authors:  J A Levy; W P Rowe
Journal:  Virology       Date:  1971-09       Impact factor: 3.616

4.  An acidic protein isolated from fibrous astrocytes.

Authors:  L F Eng; J J Vanderhaeghen; A Bignami; B Gerstl
Journal:  Brain Res       Date:  1971-05-07       Impact factor: 3.252

5.  Astrocytes present myelin basic protein to encephalitogenic T-cell lines.

Authors:  A Fontana; W Fierz; H Wekerle
Journal:  Nature       Date:  1984 Jan 19-25       Impact factor: 49.962

6.  Formation and growth of multicellular spheroids of human origin.

Authors:  J Carlsson; K Nilsson; B Westermark; J Pontén; C Sundström; E Larsson; J Bergh; S Påhlman; C Busch; V P Collins
Journal:  Int J Cancer       Date:  1983-05-15       Impact factor: 7.396

7.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

Review 8.  Autopsy pathology in the acquired immune deficiency syndrome.

Authors:  C M Reichert; T J O'Leary; D L Levens; C R Simrell; A M Macher
Journal:  Am J Pathol       Date:  1983-09       Impact factor: 4.307

9.  Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas.

Authors:  D D Bigner; S H Bigner; J Pontén; B Westermark; M S Mahaley; E Ruoslahti; H Herschman; L F Eng; C J Wikstrand
Journal:  J Neuropathol Exp Neurol       Date:  1981-05       Impact factor: 3.685

10.  Fluorescent phycobiliprotein conjugates for analyses of cells and molecules.

Authors:  V T Oi; A N Glazer; L Stryer
Journal:  J Cell Biol       Date:  1982-06       Impact factor: 10.539

View more
  98 in total

Review 1.  Neurotoxicity of macrophages infected by HIV1.

Authors:  M Tardieu; C Hery; S Peudenier
Journal:  Cell Biol Toxicol       Date:  1992 Jul-Sep       Impact factor: 6.691

2.  Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus.

Authors:  C Cheng-Mayer; C Weiss; D Seto; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  Generation and characterization of the human immunodeficiency virus type 1 mutants.

Authors:  A Adachi; N Ono; H Sakai; K Ogawa; R Shibata; T Kiyomasu; H Masuike; S Ueda
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Molecular characterization of biologically diverse envelope variants of human immunodeficiency virus type 1 derived from an individual.

Authors:  R S Daniels; M H Smith; A G Fisher
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

5.  CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4.

Authors:  N Thieblemont; N Haeffner-Cavaillon; A Ledur; J L'Age-Stehr; H W Ziegler-Heitbrock; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

6.  Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.

Authors:  J P Taylor; R J Pomerantz; G V Raj; F Kashanchi; J N Brady; S Amini; K Khalili
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  Expression of a human immunodeficiency virus type 1 long terminal repeat/simian virus 40 early region fusion gene in transgenic mice.

Authors:  J Skowronski
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

8.  Sequences from myeloblastosis-associated virus MAV-2(O) and UR2AV involved in the formation of plaques and the induction of osteopetrosis, anemia, and ataxia.

Authors:  R E Aurigemma; J L Torgersen; R E Smith
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

9.  Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1.

Authors:  J E Merrill; Y Koyanagi; J Zack; L Thomas; F Martin; I S Chen
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Localization of the viral antigen of feline immunodeficiency virus in the lymph nodes of cats at the early stage of infection.

Authors:  T Toyosaki; T Miyazawa; T Furuya; K Tomonaga; Y S Shin; M Okita; Y Kawaguchi; C Kai; S Mori; T Mikami
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.